You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
嘉和美康(688246.SH):2021年度淨利預增111.61%-182.15%
格隆匯 01-28 16:15

格隆匯1月28日丨嘉和美康(688246.SH)披露2021年度業績預增公吿,預計2021年度實現歸屬於母公司所有者的淨利潤4500萬元至6000萬元,同比增長111.61%182.15%;預計2021年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤3500萬元至5000萬元,同比增長66.83%138.33%。業績變化的主要原因系:

(一)2021年,新冠疫情在全國多地發生,一方面影響了醫院客户的正常業務開展,另一方面在部分時段限制了人員流動,導致公司在部分省市的業務開展受到了一定程度的不利影響。特別是第四季度疫情發生地涉及公司客户及項目集中的多個省份,致使部分項目驗收、項目收款工作受阻延後。公司2021年末在執行未驗收訂單形成的存貨與上年同期相比增加1.60億元1.80元。

(二)報吿期內,受益於產品佈局符合當前行業發展趨勢、新產品的成熟度不斷提升等多重因素,在全年均有新冠疫情影響及醫療器械生產業務進入收縮關停階段的背景下,公司主營業務收入仍然保持了較好的增長趨勢。公司軟件產品化率持續提高,自產軟件產品銷售收入同比增長35%-40%;同時,受此影響軟件開發及技術服務收入增長放緩,同比增長約8%-12%。

(三)公司對業務領域進行梳理,對業務佔比很小的醫療器械生產業務進行收縮關停,2021年相關收入減少約2000萬元,醫療器械業務關停造成的虧損約500-600萬元,上年同期此項業務盈利約為800萬元。

(四)2021年公司繼續加大研發投入,重點關注電子病歷智能化、專科化方向及數據利用方向,研發費用較上年增加30%-35%。

(五)報吿期內,預計實現非經常性損益金額約1000萬元,較上年同期增加約970萬元,主要為當期收到的科研課題經費及成果轉化政府補助。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account